肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

X染色体遗传学与人类癌症

X-Chromosome Genetics and Human Cancer

原文发布日期:2004-08-01

DOI: 10.1038/nrc1413

类型: Review Article

开放获取: 否

要点:

要点翻译:

英文摘要:

摘要翻译: 

原文链接:

文章:

X染色体遗传学与人类癌症

X-Chromosome Genetics and Human Cancer

原文发布日期:2004-08-01

DOI: 10.1038/nrc1413

类型: Review Article

开放获取: 否

 

要点:

  1. Although female mammals carry two copies of the X chromosome, both male and female mammalian cells carry a single active X chromosome, as in females one copy of the X chromosome is inactivated.
  2. Both of the main types of genetic alterations that lead to cancer — tumour-suppressor inactivation and oncogene activation — act dominantly when they affect the single active copy of an X-linked gene. The same alterations remain silent when they affect the inactivated X chromosome in female cells.
  3. Increased dosage of X-linked genes is thought to represent a key event in oncogenesis. Two principal mechanisms that achieve such change in gene dosage are commonly observed in tumours: gain of whole copies or regions of the active X chromosome and loss or skewing of the inactivation mechanism.
  4. As for autosomal genes, the expression of X-linked genes can be altered by changes in methylation, in addition to classic genetic mutations. Increases and decreases in methylation of X-chromosome genes have been implicated in certain cancers.
  5. Some genes that are located on the inactive X chromosome escape inactivation in normal cells and several of these are implicated in human cancer.
  6. Translocations involving regions of the X chromosome have unique outcomes in relation to ability to cause cancer. Events involving relocation of regions of the inactive X chromosome to an autosome can result in the reactivation of previously silent X-linked genes, with potential oncogenic effects. Conversely, loss of expression of an autosomal tumour suppressor can result from translocation to the inactive X chromosome.
  7. Defects in the X-chromosome inactivation process can lead to cancer. The BRCA1 tumour suppressor is thought to have a key role in X-chromosome inactivation, and it has been proposed that loss of this function contributes to the development of cancer when normal expression of this gene is lost.

 

要点翻译:

  1. 尽管雌性哺乳动物携带两条X染色体,但雌雄哺乳动物细胞中都只有一条活性X染色体,因为雌性细胞中的一条X染色体会失活。
  2. 导致癌症的两类主要遗传变异——肿瘤抑制基因失活和癌基因激活——在影响X连锁基因的唯一活性拷贝时均呈现显性作用。而当这些变异影响雌性细胞中的失活X染色体时,它们将保持沉默。
  3. X连锁基因剂量增加被认为是致癌过程中的关键事件。肿瘤中常见两种实现基因剂量改变的主要机制:获得活性X染色体的完整拷贝或区域,以及失活机制的缺失或偏斜。
  4. 与常染色体基因类似,除经典基因突变外,X连锁基因的表达还可通过甲基化水平改变而发生变化。X染色体基因甲基化水平升高或降低与特定癌症的发生相关。
  5. 部分位于失活X染色体上的基因在正常细胞中会逃脱失活,其中若干基因已被证实与人类癌症相关。
  6. 涉及X染色体区域的易位在致癌能力方面具有独特表现:当失活X染色体区域易位至常染色体时,可能重新激活原本沉默的X连锁基因,产生潜在致癌效应;反之,常染色体肿瘤抑制基因若易位至失活X染色体则可能导致其表达缺失。
  7. X染色体失活过程缺陷可诱发癌症。BRCA1肿瘤抑制基因被认为在X染色体失活中起关键作用,有研究提出当该基因正常表达缺失时,此项功能的丧失会促进癌症发展。

 

英文摘要:

In mammals, the X chromosome is unique within the chromosome set. In contrast to the other chromosomes — for which two active copies are present — both male and female cells carry only one active X chromosome. This is because males have only one X chromosome and in females only one copy is active, a situation that leads to specific characteristics for genes located on this chromosome. How are the outcomes of genetic events involved in cancer — namely activation of oncogenes and inactivation of tumour suppressors — expected to be different when these genes are carried on the X chromosome rather than on autosomes?

摘要翻译: 

在哺乳动物中,X染色体在整个染色体组中是独特的。与其他染色体不同——后者通常存在两个活跃拷贝——无论雄性还是雌性细胞,都仅携带一条活跃的X染色体。这是因为雄性只有一条X染色体,而雌性虽有两条X染色体,却也只有一条保持活性,这一状况导致位于该染色体上的基因具有特定特征。那么,当涉及癌症的遗传事件——即原癌基因的激活与抑癌基因的失活——其后果,在这些基因位于X染色体而非常染色体上时,预计会有何不同?

原文链接:

X-Chromosome Genetics and Human Cancer

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……